Dr. Goldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2020 Santa Monica Blvd.
Suite 600
Santa Monica, CA 90404Phone+1 310-633-8400Fax+1 310-633-8400- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
University of California (San Francisco)Residency, Internal Medicine, 2001 - 2004
Stanford University School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2003 - 2025
Clinical Trials
- A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01
- A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01
- Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.Masahiro Tsuboi, Roy S Herbst, Thomas John, Terufumi Kato, Margarita Majem, Christian Grohé, Jie Wang, Jonathan W Goldman, Shun Lu, Filippo de Marinis, Frances A Sheph...> ;Targeted Oncology. 2024 Mar 1
- 1 citationsSafety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-S...Trudy C Wu, Annalise Stube, Carol Felix, Denise Oseguera, Tahmineh Romero, Jonathan Goldman, Edward B Garon, Jay M Lee, John Glaspy, Aaron E Lisberg, Chad G Rusthoven,...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Sep 1
- 1 citationsBrief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.Clayton P Smith, Michael Xiang, Stephanie M Yoon, Alan Lee, Dan Ruan, Jonathan W Goldman, Amy L Cummings, Aaron Lisberg, Edward B Garon, Drew Moghanaki> ;JTO Clinical and Research Reports. 2023 Mar 1
- Join now to see all
Lectures
- Safety and antitumor activity of durvalumab monotherapy in patients with pretreated extensive disease small-cell lung cancer (ED-SCLC).2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- A randomized phase 3 study of abemaciclib versus erlotinib in previously treated patients with stage IV NSCLC with KRAS mutation: JUNIPER.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
CASPIAN Trial Update: Phase 3 Results & PerspectivesJune 23rd, 2020
FDA Approves Durvalumab plus Standard of Care for SCLCMarch 30th, 2020
FDA Approves Durvalumab plus Standard of Care Chemo for Extensive-Stage SCLCMarch 30th, 2020- Join now to see all
Hospital Affiliations
Providence Saint John's Health CenterSanta Monica, California
UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
